REQUEST A DEMO
Total
USD $0.00
Search more companies

Gl Pharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing
Full name: Gl Pharma S.A.S. Profile Updated: August 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Gl Pharma S.A.S. is based in Colombia. The head office is in Cali. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on October 02, 2019. There are currently 1 (2025) people employed by Gl Pharma S.A.S.. In, 2024, the company’s net profit margin increased by 0.57%.

Headquarters
Kr 83 # 14 - 130 Of 401
Cali; Valle del Cauca;

Contact Details: Purchase the Gl Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Gl Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Gl Pharma S.A.S. report to view the information.
Incorporation Date:
October 02, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gl Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
0%
Total operating revenue
0%
Operating profit (EBIT)
-3.51%
Net Profit (Loss) for the Period
3.64%
Total Assets
0%
Total Equity
0%
Operating Profit Margin (ROS)
-0.57%
Net Profit Margin
0.57%
Return on Equity (ROE)
3.74%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?